A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
You may notice: Less frequent sexual thoughts or spontaneous arousal Difficulty maintaining erections Decreased satisfaction or performance Fatigue, irritability, or loss of motivation Because testosterone influences both physical and emotional pathways, low levels disrupt more than just libido
3 kg x 6 mg/kg 20 mg/ml = 0.9 ml of GS-441524 daily injection
It shielded the brain from various insults: in one study, BPC-157 reduced brain swelling and neuronal death in rats who had traumatic brain injury or stroke-like conditions
Cyril Jonas Planilla: nothing to disclose, Dr
